Japan· JP-3999442G2020
イキセキズマブ（遺伝子組換え）
A medicinal product containing イキセキズマブ（遺伝子組換え）, registered in Japan by 日本イーライリリー, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- イキセキズマブ（遺伝子組換え）
- Manufacturer
- 日本イーライリリー
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
イキセキズマブ（遺伝子組換え） in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesTALTZEli Lilly and Company
- CzechiaTALTZEli Lilly and Company (Ireland) Limited, Kinsale
- BelgiumTaltz 40 mgEli Lilly and Company (Ireland)
- SwitzerlandTaltz 40 mg, solution injectable en seringue préremplieEli Lilly (Suisse) SA
- FinlandTaltzEli Lilly and Company (Ireland) Limited
- IrelandTaltz 40mg Solution for injectionEli Lilly Kinsale Limited
- IcelandTaltzEli Lilly and Company (Ireland) Limited
- NetherlandsTaltz 40 mg oplossing voor injectie in voorgevulde injectiespuitEli Lilly and Company (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Taltz
- Liechtenstein · Taltz
- Norway · Taltz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b25bc858-8816-4561-96f2-84ad97692ee3 GET /v1/drugs/b25bc858-8816-4561-96f2-84ad97692ee3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "８０ｍｇ１ｍＬ１キット",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3999442G2020",
"category": "注射薬",
"price_yen": 148952,
"generic_name": "イキセキズマブ（遺伝子組換え）",
"product_name_jp": null,
"therapeutic_class": "3999",
"transitional_expiry": null
}See everything about イキセキズマブ（遺伝子組換え）.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.